Get Prepared For A Passel Of EU Legislation On Copyright And Related Rights 21/11/2017 by Monika Ermert for Intellectual Property Watch 2 Comments This week several committees in the European Parliament voted on a pile of copyright-related dossiers, and in some instances the steps taken were really small. But the issues include controversial aspects in the legislative drafts on copyright review, broadcasting content and digital content, such as an obligation for providers to monitor third party content, intermediary liability and website blocking.
Studies Presented At WIPO To Better Understand Limitations To Copyright 17/11/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment With no consensus on conducting normative work at the World Intellectual Property Organization on the limitations to copyright for certain actors such as persons with disabilities, educational institutions, and museums, the committee on copyright had agreed on several studies so the issues are better understood. This week, several of those studies were presented to the committee and shed some further light on the issues.
Infojustice – US, Canadian & Mexican Law Professors, Academics And Policy Experts: NAFTA Must Include Fair Use, Safe Harbors 15/11/2017 by Intellectual Property Watch 1 Comment WASHINGTON – Today, over seventy international copyright law experts called for NAFTA and other trade negotiators to support a set of balanced copyright principles. The experts urge trade negotiators to support policies like fair use, safe harbor provisions, and other exceptions and limitations that permit and encourage access to knowledge, flourishing creativity, and innovation. Signatories include preeminent intellectual property professors and experts from law schools, think tanks, and public interest organizations in the U.S., Canada, and Mexico, as well as Argentina, Australia, China, Ireland, and Switzerland.
Special Report: A Look Behind Hepatitis C Patent Challenges Worldwide 15/11/2017 by Tatum Anderson for Intellectual Property Watch 2 Comments A case at the High Court in India set for 15 December could decide whether a patent on some of the most important drugs to fight hepatitis C should be removed. It is one of many attempts to challenge patents on hepatitis C drugs in various countries around the world and serves as an opportunity to learn more about the group leading the legal case.
‘Damaging’ Provisions On IP Dropped From TPP Agreement, MSF Says 15/11/2017 by William New, Intellectual Property Watch Leave a Comment Trade ministers negotiating the Trans-Pacific Partnership (TPP) without the United States have dropped many problematic provisions related to intellectual property and health, Médicins Sans Frontières (MSF, Doctors Without Borders) reported today. Also removed from the agreement appears to be the investor-state dispute settlement provisions, according to a source.
As Global Fund Board Meets To Choose New Director, Sands Seeks To Reinstate Candidacy 13/11/2017 by William New, Intellectual Property Watch Leave a Comment Days after withdrawing from consideration to be the next director of the Global Fund for AIDS, Tuberculosis and Malaria, the UK’s Peter Sands has asked to be reinstated. The actions come as the Fund’s Board gathers this week to choose among the final candidates for head of the international health funding organisation based in Geneva.
Next Global Congress On IP And The Public Interest 13/11/2017 by Intellectual Property Watch Leave a Comment American University Washington College of Law (AUWCL) Program on Information Justice and Intellectual Property has announced the hosting of Fifth Global Congress on Intellectual Property and the Public Interest, from 27-29 September 2018. And it is now actively seeking sponsors, partners and expressions of interest.
First Consultations Held On WHO Pandemic Flu Framework Options 10/11/2017 by Catherine Saez, Intellectual Property Watch 2 Comments The World Health Organization is consulting member states and stakeholders on the future of its mechanism to help prepare the world for the next influenza pandemic. It is particularly asking whether countries should submit not only the biological samples of their influenza viruses, but also their genetic information through the mechanism. Also in question is whether the mechanism should be extended to cover seasonal influenza. Stakeholders had different views but all questioned the absence of recognition by the WHO of a widely used database currently hosting most of the world’s influenza genetic information.
WIPO Vaccines Report Contestable, With UN High-Level Panel Misquoted, Advocate Says 10/11/2017 by Intellectual Property Watch Leave a Comment The World Intellectual Property Organization this week held an event that delved into research, markets and access for vaccines with panels that showed unusual breadth of representation for the UN IP agency. But health advocates have taken issue with the wording of a report released by WIPO at the event.
New WHO 5-Year Programme Is Out. In The Recipe? SDGs, Access To Medicines, Innovation, Better Health For All 01/11/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The new leadership of the World Health Organization today issued its draft new programme of work for the next five years. The programme depicts new orientations for the global health actor, starting with the alignment of the programme with the United Nations Sustainable Development Goals and universal health coverage. The organisation also commits to help establish policies promoting access to health products, including generic medicines, innovation, and fair pricing. The WHO is set to help address innovation barriers, and to step up its global leadership, but asks that its members actually fully finance the budget that they approve.